Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene

Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene

US Patent 9856295 · Granted Jan 2, 2018

Estimated economic value: $142,498,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant viral vector systems expressing exogenous feline paramyxovirus genes2021
Inactivated canine influenza vaccines and methods of making and uses thereof2020
Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof2020
FCV recombinant vaccines and uses thereof2019
Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof2018
Mutated non-primate lentiviral Env proteins and their use as drugs2018
Mutant human and simian immunodeficiency virus ENV proteins with reduced immunos2017
Recombinant feline leukemia virus vaccine containing optimized feline leukemia v2017
Recombinant feline leukemia virus vaccine containing optimized feline leukemia v2017
Mutant human and simian immunodeficiency virus ENV proteins with reduced immunos2017
Newcastle disease virus vectored herpesvirus vaccines2016
Newcastle disease virus vectored herpesvirus vaccines2015